Review



etrasimod standard  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    MedChemExpress etrasimod standard
    Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator <t>etrasimod.</t>
    Etrasimod Standard, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etrasimod standard/product/MedChemExpress
    Average 92 stars, based on 1 article reviews
    etrasimod standard - by Bioz Stars, 2026-03
    92/100 stars

    Images

    1) Product Images from "Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling"

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    Journal: Heliyon

    doi: 10.1016/j.heliyon.2024.e34066

    Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator etrasimod.
    Figure Legend Snippet: Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator etrasimod.

    Techniques Used:

    Stability-indicating method validation data for determination of etrasimod.
    Figure Legend Snippet: Stability-indicating method validation data for determination of etrasimod.

    Techniques Used: Quantitation Assay

    Representative chromatograms of etrasimod under acidic (A), oxidative (B), and photolytic (C) stress conditions.
    Figure Legend Snippet: Representative chromatograms of etrasimod under acidic (A), oxidative (B), and photolytic (C) stress conditions.

    Techniques Used:

    Forced degradation study results.
    Figure Legend Snippet: Forced degradation study results.

    Techniques Used:

    Retention and mass spectrometric data of etrasimod and degradation products obtained by forced degradation study.
    Figure Legend Snippet: Retention and mass spectrometric data of etrasimod and degradation products obtained by forced degradation study.

    Techniques Used:

    MS and MS/MS spectra of etrasimod: positive ESI-MS spectrum ( A ), negative ESI-MS spectrum ( B ), and ESI-MS/MS spectrum of [M+H] + ion ( m/z 458) with proposed fragmentation pattern ( C ).
    Figure Legend Snippet: MS and MS/MS spectra of etrasimod: positive ESI-MS spectrum ( A ), negative ESI-MS spectrum ( B ), and ESI-MS/MS spectrum of [M+H] + ion ( m/z 458) with proposed fragmentation pattern ( C ).

    Techniques Used: Tandem Mass Spectroscopy

    The ComplexGAPI pictogram of etrasimod forced degradation study. Legend: 1 – collection, 2 – preservation, 3 – transport, 4 – storage, 5 – type of method, 6 – scale of extraction, 7 – solvents/reagents used, 8 – additional treatment, 9 – amount of reagents and solvents, 10 – health hazard of reagents and solvents, 11 – safety hazard of reagents and solvents, 12 – instrumentation energy, 13 – occupational hazard, 14 – waste, 15 – waste treatment, I – yield, II – pre-analysis temperature and time, III – relation to green economy, IV a – health hazard of reagents and solvents used in pre-analysis, IV b – safety hazard of reagents and solvents used in pre-analysis, V a – technical set up, V b – energy of instruments used in pre-analysis, V c – occupational hazard of pre-analysis, VI a – end products workup, VI b – purity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
    Figure Legend Snippet: The ComplexGAPI pictogram of etrasimod forced degradation study. Legend: 1 – collection, 2 – preservation, 3 – transport, 4 – storage, 5 – type of method, 6 – scale of extraction, 7 – solvents/reagents used, 8 – additional treatment, 9 – amount of reagents and solvents, 10 – health hazard of reagents and solvents, 11 – safety hazard of reagents and solvents, 12 – instrumentation energy, 13 – occupational hazard, 14 – waste, 15 – waste treatment, I – yield, II – pre-analysis temperature and time, III – relation to green economy, IV a – health hazard of reagents and solvents used in pre-analysis, IV b – safety hazard of reagents and solvents used in pre-analysis, V a – technical set up, V b – energy of instruments used in pre-analysis, V c – occupational hazard of pre-analysis, VI a – end products workup, VI b – purity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Techniques Used: Preserving, Extraction

    The AGREE pictogram of etrasimod forced degradation study. Legend: 1 – sample procedure, 2 – sample size, 3 – sampling, 4 – sample preparation steps, 5 – automatization, 6 – derivatization, 7 – waste, 8 – analysis throughput, 9 – energy consumption, 10 – renewable reagents, 11 – toxicity of reagents, 12 – operator’ safety.
    Figure Legend Snippet: The AGREE pictogram of etrasimod forced degradation study. Legend: 1 – sample procedure, 2 – sample size, 3 – sampling, 4 – sample preparation steps, 5 – automatization, 6 – derivatization, 7 – waste, 8 – analysis throughput, 9 – energy consumption, 10 – renewable reagents, 11 – toxicity of reagents, 12 – operator’ safety.

    Techniques Used: Sampling, Sample Prep

    The AGREEprep pictogram of etrasimod forced degradation study. Legend: AGREEprep: 1 – sampling, 2 – hazardous materials, 3 – sustainability, renewability, and reusability of materials, 4 – waste, 5 – economy of a sample, 6 – sample throughput, 7 – automatization, 8 – energy consumption, 9 – analytical instrumentation, 10 – operator's safety.
    Figure Legend Snippet: The AGREEprep pictogram of etrasimod forced degradation study. Legend: AGREEprep: 1 – sampling, 2 – hazardous materials, 3 – sustainability, renewability, and reusability of materials, 4 – waste, 5 – economy of a sample, 6 – sample throughput, 7 – automatization, 8 – energy consumption, 9 – analytical instrumentation, 10 – operator's safety.

    Techniques Used: Sampling



    Similar Products

    etrasimod standard  (MedChemExpress)
    92
    MedChemExpress etrasimod standard
    Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator <t>etrasimod.</t>
    Etrasimod Standard, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/etrasimod standard/product/MedChemExpress
    Average 92 stars, based on 1 article reviews
    etrasimod standard - by Bioz Stars, 2026-03
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator etrasimod.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: Chemical structure of sphingosine-1-phosphate (S1P) receptor modulator etrasimod.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques:

    Stability-indicating method validation data for determination of etrasimod.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: Stability-indicating method validation data for determination of etrasimod.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques: Quantitation Assay

    Representative chromatograms of etrasimod under acidic (A), oxidative (B), and photolytic (C) stress conditions.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: Representative chromatograms of etrasimod under acidic (A), oxidative (B), and photolytic (C) stress conditions.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques:

    Forced degradation study results.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: Forced degradation study results.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques:

    Retention and mass spectrometric data of etrasimod and degradation products obtained by forced degradation study.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: Retention and mass spectrometric data of etrasimod and degradation products obtained by forced degradation study.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques:

    MS and MS/MS spectra of etrasimod: positive ESI-MS spectrum ( A ), negative ESI-MS spectrum ( B ), and ESI-MS/MS spectrum of [M+H] + ion ( m/z 458) with proposed fragmentation pattern ( C ).

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: MS and MS/MS spectra of etrasimod: positive ESI-MS spectrum ( A ), negative ESI-MS spectrum ( B ), and ESI-MS/MS spectrum of [M+H] + ion ( m/z 458) with proposed fragmentation pattern ( C ).

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques: Tandem Mass Spectroscopy

    The ComplexGAPI pictogram of etrasimod forced degradation study. Legend: 1 – collection, 2 – preservation, 3 – transport, 4 – storage, 5 – type of method, 6 – scale of extraction, 7 – solvents/reagents used, 8 – additional treatment, 9 – amount of reagents and solvents, 10 – health hazard of reagents and solvents, 11 – safety hazard of reagents and solvents, 12 – instrumentation energy, 13 – occupational hazard, 14 – waste, 15 – waste treatment, I – yield, II – pre-analysis temperature and time, III – relation to green economy, IV a – health hazard of reagents and solvents used in pre-analysis, IV b – safety hazard of reagents and solvents used in pre-analysis, V a – technical set up, V b – energy of instruments used in pre-analysis, V c – occupational hazard of pre-analysis, VI a – end products workup, VI b – purity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: The ComplexGAPI pictogram of etrasimod forced degradation study. Legend: 1 – collection, 2 – preservation, 3 – transport, 4 – storage, 5 – type of method, 6 – scale of extraction, 7 – solvents/reagents used, 8 – additional treatment, 9 – amount of reagents and solvents, 10 – health hazard of reagents and solvents, 11 – safety hazard of reagents and solvents, 12 – instrumentation energy, 13 – occupational hazard, 14 – waste, 15 – waste treatment, I – yield, II – pre-analysis temperature and time, III – relation to green economy, IV a – health hazard of reagents and solvents used in pre-analysis, IV b – safety hazard of reagents and solvents used in pre-analysis, V a – technical set up, V b – energy of instruments used in pre-analysis, V c – occupational hazard of pre-analysis, VI a – end products workup, VI b – purity. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques: Preserving, Extraction

    The AGREE pictogram of etrasimod forced degradation study. Legend: 1 – sample procedure, 2 – sample size, 3 – sampling, 4 – sample preparation steps, 5 – automatization, 6 – derivatization, 7 – waste, 8 – analysis throughput, 9 – energy consumption, 10 – renewable reagents, 11 – toxicity of reagents, 12 – operator’ safety.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: The AGREE pictogram of etrasimod forced degradation study. Legend: 1 – sample procedure, 2 – sample size, 3 – sampling, 4 – sample preparation steps, 5 – automatization, 6 – derivatization, 7 – waste, 8 – analysis throughput, 9 – energy consumption, 10 – renewable reagents, 11 – toxicity of reagents, 12 – operator’ safety.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques: Sampling, Sample Prep

    The AGREEprep pictogram of etrasimod forced degradation study. Legend: AGREEprep: 1 – sampling, 2 – hazardous materials, 3 – sustainability, renewability, and reusability of materials, 4 – waste, 5 – economy of a sample, 6 – sample throughput, 7 – automatization, 8 – energy consumption, 9 – analytical instrumentation, 10 – operator's safety.

    Journal: Heliyon

    Article Title: Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling

    doi: 10.1016/j.heliyon.2024.e34066

    Figure Lengend Snippet: The AGREEprep pictogram of etrasimod forced degradation study. Legend: AGREEprep: 1 – sampling, 2 – hazardous materials, 3 – sustainability, renewability, and reusability of materials, 4 – waste, 5 – economy of a sample, 6 – sample throughput, 7 – automatization, 8 – energy consumption, 9 – analytical instrumentation, 10 – operator's safety.

    Article Snippet: Etrasimod standard was purchased from MedChemExpress (Monmouth Junction, NJ, USA) with purity of 99.82 % (according to supplier certificate analysis).

    Techniques: Sampling